Terbinafine hydrochloride is a synthetic allylamine antifungal has been developed as a new class of ergosterol biosynthetic inhibitors that are functionally as well as chemically distinct from the other major classes of ergosterol-inhibiting antifungal agents (Ryder et al., 1984; Ryder and Favre, 1997) . The mechanism of action of terbinafine involves the specific inhibition of fungal squalene epoxidase, resulting in ergosterol deficiency and accumulation of intracellular squalene, which appears to be identical in dermatophytes, molds, and yeasts (Ryder, 1992; Graminha et al., 2004) .
C. albicans resistance to antifungal agent is due to expression of resistance gene(s) associated with antifungal treatment. These genes include Candida drug resistance genes (CDR1 and CDR2) they encoding transporters of ATP-binding cassette (ABC) family; multi-drug resistance gene (CaMDR1) which coding a major facilitator transporters (MFT) family; fluconazole-resistance genes; (FLU1) and (ERG11) encoding lanosterol 14-α demethylase (Chen et al., 2010) .
The objective of the present study was to assay the susceptibility of C. albicans isolates to some antifungals. The upregulation of some resistance genes in C. albicans in response to antifungal treatments were also studied.
Material and Methods

Antifungal assay by disk-diffusion susceptibility method
The primary screening of C. albicans isolates was carried out by the diskdiffusion method using agar medium (CLSI M44-A), according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2009 ). The antifungal drugs showing an inhibitory effect on the growth of the tested Candida isolates was monitored as an appearance of growth inhibition zone (GIZ).
Estimation of minimum inhibitory concentration (MIC 90 ) using broth microdilution technique (M27-A2)
Liquid RPMI 1640 medium with L-glutamine and 2% glucose but without bicarbonate (Rodriguez-Tudela et al., 1996) was buffered with morpholinepropanesulfonic acid (MOPS) to pH 7 at 25°C, and applied in sterile 96 round-bottom wells microtiter plate made of polypropylene (Nunc ® , Roskilde, Denmark) containing different dilutions of antifungal. Thawing was accomplished by setting the inocu lated plates in the 4°C refrigerator for 1 hr leaving them at room temperature for another 1hr, and finally placing them in the 35°C incubator for 15 to 30 min to minimize condensation formation on the plate lids. The plate lids also were propped up slightly to allow evaporation of condensate during all three stages of the thawing procedure. MIC 90 was defined as the concentration of the antifungal that inhibit 90% of the C. albicans growth.
Resistance gene expressions in C. albicans isolates Total RNA isolation
For each isolate, an overnight culture was propagated in fresh yeast extract peptone dextrose broth with constant shaking at 30°C until the mid-logarithmic phase was reached. Total cellular RNA was extracted with the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the supplier's instruction. Possible genomic DNA contamination was removed by RNase-free DNase I (Fermentas Life Sciences, Burlington, ON, Canada) treatment. Total RNA concentrations were determined spectrophotometrically at 260nm using a spectrophotometer (SHIMADZU UV-1650PC, Japan): a ratio of A 260 nm: A 280 nm of 1.8-2.0 corresponded to 90-100% pure nucleic acid. Analytical denaturing RNA electrophoresis in TAE agarose gels was carried out based on the method of Masek et al. (2005) employing the Tris-acetate-EDTA buffer (TAE) with denaturation of the sample in 50% formamide prior to electrophoresis.
Reverse transcription polymerase chain reaction (RT-PCR) analysis
In order to determine expression genes patterns of C. albicans CDR1, CDR2, ERG11, FLU1 and CaMDR1 semi-quantitatively, RT-PCR was conducted on total RNA extracted from the most susceptible-and most resistant isolates to fluconazole and terbinafine either white or opaque isolates (Table 1) . The cDNA for each strain was synthesized using the extracted total RNA with 200 units of RevertAid™ M-MuLV Reverse Transcriptase from the RevertAid™ First Strand cDNA Synthesis Kit (Fermentas Life Sciences) and an oligo (dT) primer [a cDNA synthesis primer (10 μM)] with the dNTP mixture (10 mM). The generated cDNA was then used as a template in PCR reactions. The PCR primers used to amplify and identify the C. albicans CDR1, CDR2, ERG11, FLU1 and CaMDR1 genes were designed with Primer Premier 5.0 design software (Premier Biosoft International, Palo Alto, CA, USA) and synthesized by BIONEER Inc. (Dalian, Korea). The housekeeping gene 18SrRNA was used as a control. The nucleotide sequences of the primers are given (Table 2) . 
ERG11, lanosterol 14α-demethylase gene; CDR1, Candida drug resistance 1 gene; CDR2, Candida drug resistance 2 gene; CaMDR1, Candida multidrug resistance 1 gene; FLU1, fluconazole resistance 1 gene. F, Forward; R: reverse.
In this study different PCR assays were performed in 25µL PCR reaction volume. The amplification was performed in a programmable heating block (Primus Thermal Cycler, MWG Biotech, Germany). The PCR conditions for all the genes except ERG11 was: Initial denaturation of 95°C for 3 min followed by 40 cycles of denaturation at 95°C for 45 seconds, annealing at 50°C for 45 seconds, and extension at 72°C for 1 min. While, the PCR conditions for ERG11 was: Initial denaturation of 95°C for 3 min, followed by 40 cycles of denaturation at 95°C for 45 seconds, annealing at 42°C for 45 seconds, and extension at 72°C for 1 min, followed by final extension at 72°C for 10 min.
Visualization and quantitation of PCR products
After amplification, 10µl of each PCR product was mixed with 2µl of the orange/Blue 6X loading dye (Promega). Samples were electrophoresed on 1.5% agarose gel in 0.5xTBE buffer containing 0.5µg/ml ethidium bromides for 50-60 minutes at 70 volts in a minigel electrophoresis unit using 0.5xTBE as electrophoresis buffer. Amplification products were visualized and photographed using ultraviolet transilluminator. The sizes of the amplification products were compared with either the 100 bp ladder DNA marker that was loaded with the samples simultaneously. Quantitation of RT-PCR produced band intensity, strength, was carried out in Image J software.
Statistical analyses
Duncan test was executed to show homogeneity among the means at (P<0.05). Statistical analyses were performed using SPSS software (version 15; SPSS, Chicago, IL). Table 3 reveal that the opaque isolates C1 and C3 were more susceptible to FLU than the white ones, C2 and C4. The highly resistant isolate C4 was collected from blood of a male of 2 months age, suffering from immunodeficiency and treated with three types of antibiotics. On the other hand, the highly susceptible isolate C1 was collected from the urine of a male of 2 months age suffering from pynophrosis and treated with two types of antibiotics. Similar trend of result in case of TRB was observed when compared with FLU (Table 4) where the opaque C. albicans isolates C5 and C7 were more susceptible than the white ones (C6 and C7) and recorded lower MIC 90 against TRB. The highly susceptible opaque isolate C5 to TRB was collected from the blood of a twelve days old female suffering from ectopia vesicae and tetralogy of fallot (TOF), and treated with two types of antibiotics, while the highly resistant white isolate C8 was isolated from blood of a two days old male suffering from skin cancer. Gene expression in C. albicans treated with antifungals Expression of gene transcripts encoding both fluconazole and terbinafine resistance proteins was analyzed by semi-quantitative RT-PCR (Semi Q RT-PCR) for isolation of total RNA from different C. albicans isolates (Fig. 1) . The PCR product of the C. albicans isolates resulted in a clear band on ethidium bromide stained, UVtransilluminated agarose gel. A single band of PCR product with the expected length on agarose gel electrophoresis also confirmed the specificity of the PCR reactions. The expression levels of genes encoding lanosterol 14α-demethylase (ERG11) ; efflux transporters Candida multidrug resistance protein1 (CaMDR1) ; Candida drugresistance CDR1 and CDR2 and the major facilitator fluconazole-resistance gene (FLU1) implicated in fluconazole-resistance in C. albicans were monitored semiquantitatively by RT-PCR in matched sets of susceptible-and resistant isolates (Fig. 2  a-f) . Upregulation folds were calculated based on relative comparison of the resistant with the susceptible strains according to MIC 90 of the tested FLU and TRB.
Results
1-Antifungal susceptibility assay
Resistance to FLU
The results showed that ERG11 transcription level was seen only in the FLU resistant opaque C. albicans isolate C3 (Fig. 2-d and Table 5 ). The CDR1 efflux gene was up regulated (1.04 and 1.02 fold) in the FLU resistant opaque isolates C3 and FLU resistant white isolate C4, respectively, compared with the susceptible opaque isolates C1 and white isolate C2, respectively. FLU resistant opaque isolate C3 had the highest CDR1 transcript level (a 1.02 fold increase than CDR1 in FLU resistant white isolate C4; oppositely, no transcripts were detected for CaMDR1, CDR2, ERG11 and FLU1, genes in the FLU-susceptible C. albicans isolates (C1 & C2) (Fig.2 b & Table 5 ). The analysis confirmed that mechanisms of fluconazole-resistance in the four tested isolates of C. albicans exhibiting a predominance of over expression of CDR1 encoding efflux pumps, detected in all tested isolates, while, over expression of the gene that encodes the enzyme 14α-demethylase (ERG11) was detected in 25% of the isolates specifically resistant opaque isolate C3 only.
Resistance to TRB
The CDR1 efflux gene in the terbinafine-resistant white isolate C8 was up regulated 1.4 fold relative to susceptible white isolate C6. Similarly, 1.04 fold increased in CDR1 transcript level was observed in resistant opaque isolate C7 relative to the susceptible opaque isolate C5, (Fig.2 b & Table 5 ). Resistant white isolate C8 had the highest CDR1 expression level. The resistant opaque isolate C7 had higher up regulation in the CDR2 transcript level (Fig.2 c) compared with the resistant white isolate C8. The expression of CaMDR1 (Fig. 2 a) and ERG11 had maximum expression in resistant opaque isolate C7 followed by white resistant isolate C8. It is worth mentioning that the susceptible white isolate C6 and resistant opaque isolate C5 did not transcript levels for CaMDR1, CDR2 or ERG11. However FLU1 gene not measured in all isolates (Table 5 ).
The expression of CDR1 resistance gene by susceptible and resistant C. albicans isolates indicated the non selectivity in expressing this gene by Candida isolates. The environmental conditions, Candida spp. and patient conditions determined whether these genes are functioning or not. Furthermore, the expression of resistant gene CDR1 by susceptible isolates indicates that it may be expressed but not functioning. CaMDR1, CDR2, ERG11 genes were expressed in resistant white and opaque C. albicans isolates only (Table 5) .
Discussion
Rapid and reliable antifungal susceptibility testing has become particularly important in recent years because of the emergency of antifungal -drug resistance (Asai et al., 1999) . Opportunistic fungal infections have dramatically increased in recent years which prompted the pharmaceutical industry to respond with development of several new antifungal agents. Consequently, interest has increased in developing standardized tests to determine antifungal drug susceptibility and in optimizing those tests to accurately predict clinical outcome (Graybill et al., 1998 ).
In the current study, susceptibility tests and MIC 90 determination were carried out on 49 Candida isolates (white and opaque forms) of C. albicans. Two antifungals with different groups and different mode of actions were tested: fluconazole (FLU) and terbinafine (TRB). Disk-diffusion test (NCCLS M44-A) was used. White-yeast form of C. albicans appeared highly susceptible to FLU and TRB. Among the 4 tested isolates of white C. albicans, isolates number C2 and C6 were highly susceptible, whereas, isolates number C4 and C8 were the most resistant to FLU and TRB, respectively. Among 4 assayed opaque C. albicans, isolate number C1 and C5 were highly susceptible to both FLU and TRB, while isolates number C3 and C7 were highly resistant to FLU and TRB, respectively. In general, the susceptibility tests indicated that opaque-form of C. albicans was more susceptible to the tested antifungals than white form.
In spite of FLU widespread use in medical community, many reports observed clinical failure in individuals with candidiasis due to FLU-resistant C. albicans strains especially in immunocompromised patients treated for chemotherapy or prophylaxis (Case et al., 1991; Martins et al., 1997; Rangel-Frausto et al., 1999; Krcmery and Barnes, 2002) . Pelletier et al. (2002) applied NCCLS M27-A method to evaluate the antifungal activity of voriconazole (VRC) and fluconazole (FLU) against 295 Candida isolates collected from 189 patients. Forty two isolates had reduced susceptibility to FLU (MIC > 8 mg/l); 83.3% of those had VRC MIC ≤ 2mg/l (9 of 11 C. albicans, 18 of 19 C. glabrata, 6 of 6 C. krusei, 2 of 2 C. Lusitania and 0.0 of 4 C. tropicalis). This suggested that VRC exhibited fungicidal activity against abroad range of commonly FLU-resistant species.
In the current study, an experiment was designed to investigate, in the molecular level, the resistance mechanisms of C. albicans to FLU and TRB by semi-quantiation of the expression of some resistance genes using RT-PCR. These genes include Candida drug-resistance genes (CDR1 and CDR2), the gene encoding lanosterol 14α-demethylase (ERG11), Fluconazole-resistance 1 gene (FLU1), and Candida multidrug-resistance 1gene (CaMDR1).
It was found that CDR1 was upregulated by all Candida isolates whether it is white or opaque resistant or susceptible to FLU and TRB. This indicated that this gene is over expressed with any antifungal treatment but is functioning in the resistant isolates only. The genes CDR2 and CaMDR1 are not expressed in all FLU treatments, while they expressed by resistant isolates (white and opaque) to TRB. ERG11 was expressed in the two resistant isolates C7& C8 to TRB and the opaque resistant isolate C3 to FLU. This means that CaMDR1, CDR2 and ERG11 genes are associated with resistance of C. albicans to antifungals. FLU1 gene was not expressed by C. albicans in all cases. It is worth noting that in all susceptible isolates CDR1 was the only expressed gene.
The most common azole resistance mechanism in C. albicans has been reported to be a reduced intracellular accumulation of the drug as a result of reduced influx and / or increased efflux (Ryley et al., 1984; Venkateswarlu et al., 1997) . Evidence has been presented that efflux of azole drugs from fungal cells is due to energy-dependent pumps (Vanden Bossche et al., 1992) . Correlation between over expression of CDR1 and CDR2 genes, which are members of ATPbinding cassette (ABC) super family, and CaMDR1 gene of Major Facilitator Super family (MSF) and azole resistance by C. albicans were detected by several investigators (Sanglard et al., 1995; 1997; White, 1997; Franz et al., 1998) . Over expression of CDR1 and CDR2 without any energy dependent efflux was demonstrated by Sanglard et al. (1995) . This suggests that although these genes expressed but they are not functioning. High expression of MDR11 in some FLUsusceptible isolates has been seen by (White et al., 2002; Goldman et al., 2004) .
CDR1, CDR2
and CaMDR1 are genes proposed to encode cell memberaneassociated transporters which act as possible mediator to enhance FLU efflux and they are responsible for the export of several azole drugs (Fling et al., 1991; Sanglard et al., 1995; 1997; White, 1997; Franz et al., 1998) . CDR2 conferred hyper resistance to the antifungal capsfungin, while it enhanced susceptibility to the antifungal micofungin. This indicated that the increased functional expression of cdr1p and cdr2p didn't give significant candin resistance in C. albicans strains. Chen et al. (2010) reported that CDR1 and CDR2 were upregulated in all FLUresistant C. albicans isolates whereas only a few isolates showed high expression of CaMDR1, FLU1 and ERG11 genes compared with control strain. They concluded that over expression of CDR1 and CDR2 genes may play role in FLUresistant C. albicans.
In all fungal species, ERG11 (gene encoding Erg11-p or lanosterol 14α-demethylase) is an essential gene for ergosterol synthesis. Over expression of ERG11 causes an increased copy number of the enzyme lanosterol 14α-demethylase and results in increased ergosterol biosynthesis which reduced the efficiency of the antifungal drugs against C. albicans (Holmberg and Stevens, 1999; Perea et al., 2002) . The alternation in pathway of ergosterol synthesis in amphotericin B-resistant C. albicans involve ERG11 gene (Liu et al., 1996) . Mutation in ergosterol synthesis pathway genes including ERG11 modifies the site of amphoteicin B activity (Kumar and Shakla, 2010) , ERG11 gene over expression result in conformational changes that reduce the effective binding between azoles and their target (Rodriguez-Tudela et al., 1996) . Despite this, an investigator has concluded that there is no obvious link between the expression levels of ERG11 and increased azole resistance (White et al., 2002) . Chen et al., (2010) indicated poor correlation between ERG11 over expression with FLU resistance. Thus, at least four common explanations of the mechanisms of azole resistance in C. albicans: 1-Alternation of drug target enzymes such as α point mutation in ERG11 that can affect the affinity between drugs and the target enzyme. 2-Overexpression of drug resistance genes in C. albicans (CDR1& CDR2) and the multidrug resistance 1 gene (CaMDR1). 3-Overexpression of the major facilitator resistance gene FLU1 which found to increase FLU-resistance by C. albicans.
